Novavax Inc. (NASDAQ: NVAX) has been a high-profile stock in the biotech sector, especially after its COVID-19 vaccine gained global attention. However, as the vaccine
Moderna Inc (MRNA) was up 20.24%on Monday at $152.74. The biotechnology company has therefore applied for marketing authorizations for its coronavirus vaccine in the United
The markets are in the green pre-market and all the major indices have recorded gains after a mixed performance on Thursday. The increased positive sentiment
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.